A single intravenous sTNFR-Fc administration at the time of reperfusion limits infarct size - Implications in reperfusion strategies in man

Cardiovascular Drugs and Therapy

Volumn 22, Issue 6, 2008, Pages 437-442

  Toufektsian, Marie Claire ^a   Robbez Masson, Vanessa ^a,b   Sanou, Drissa ^c   Jouan, Marie Gabrielle ^a   Ormezzano, Olivier ^d   De Leiris, Joël ^a   Boucher, François ^a  

^a LABORATOIRE TIMC IMAG   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^d HÔPITAL MICHALLON   (France)

Author keywords

Cardiac dysfunction; Remodelling; sTNFR Fc; TNF ; Transient ischemia

Indexed keywords

FC RECEPTOR; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR FC RECEPTOR CONJUGATE; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE OVERLOAD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ANIMALS; DATA INTERPRETATION, STATISTICAL; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; EVANS BLUE; FORECASTING; HEMODYNAMICS; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; STAINING AND LABELING; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 55949132000     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-008-6130-y     Document Type: Article

References (28)

1. NG Frangogiannis CW Smith ML Entman 2002 The inflammatory response in myocardial infarction Cardiovasc Res 53 31 47
2. NJ Jansen W van Oeveren YJ Gu MH van Vliet L Eijsman CR Wildevuur 1992 Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass Ann Thorac Surg 54 744 747
3. CP Maury AM Teppo 1989 Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction J Intern Med 225 333 336
4. G Torre-Amione S Kapadia J Lee 1996 Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart Circulation 93 704 711
5. J Gurevitch I Frolkis Y Yuhas 1996 Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion J Am Coll Cardiol 28 247 252
6. A Herskowitz S Choi AA Ansari S Wesselingh 1995 Cytokine mRNA expression in postischemic/reperfused myocardium Am J Pathol 146 419 428
7. C Moro MG Jouan A Rakotovao 2007 Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodelling Am J Physiol Heart Circ Physiol 293 H3014 H3019
8. R Schulz S Aker S Belosjorow G Heusch 2004 TNFalpha in ischemia/reperfusion injury and heart failure Basic Res Cardiol 99 8 11
9. J Gurevitch I Frolkis Y Yuhas 1997 Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion J Am Coll Cardiol 30 1554 1561
10. M McVey MH Perrone KL Clark 1999 Does tumor necrosis factor-alpha (TNFalpha) contribute to myocardial reperfusion injury in anesthetized rats? Gen Pharmacol 32 41 45
11. D Li L Zhao M Liu X Du W Ding J Zhang 1999 Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction Am Heart J 137 1145 1152
12. D Gurantz A Yndestad B Halvorsen 2005 Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling Cardiovasc Res 67 106 115
13. MF Berry YJ Woo TJ Pirolli 2004 Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling J Heart Lung Transplant 23 1061 1068
14. M Sugano T Hata K Tsuchida 2004 Local delivery of soluble TNFalpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats Mol Cell Biochem 266 127 132
15. C Berthonneche T Sulpice F Boucher 2004 New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats Am J Physiol Heart Circ Physiol 287 H340 H350
16. B Dawn Y Guo A Rezazadeh OL Wang AB Stein G Hunt 2004 Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning J Mol Cell Cardiol 37 51 61
17. F Labruto J Yang J Vaage G Valen 2005 Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia Basic Res Cardiol 100 198 207
18. A Skyschally P Gres S Hoffmann M Haude R Erbel R Schulz 2007 Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction Circ Res 100 140 146
19. S Lecour RM Smith B Woodward LH Opie L Rochette MN Sack 2002 Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection J Mol Cell Cardiol 34 509 518
20. M Tanno DA Gorog M Bellahcene X Cao RA Quinlan MS Marber 2003 Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation J Mol Cell Cardiol 35 1523 1527
21. M Sack 2002 Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease Pharmacol Ther 94 123 135
22. MJ Stampfer SZ Goldhaber S Yusuf R Peto CH Hennekens 1982 Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials N Engl J Med 307 1180 1182
23. GW Stone BR Brodie JJ Griffin 1998 Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary angioplasty in myocardial infarction stent pilot trial investigators J Am Coll Cardiol 31 23 30
24. DL Mann 2002 Inflammatory mediators and the failing heart: past, present, and the foreseeable future Circ Res 91 988 998
25. BD Shames HH Barton LL Reznikov 2002 Ischemia alone is sufficient to induce TNFl-apha mRNA and peptide in the myocardium Shock 17 114 119
26. A Deswal B Bozkurt Y Seta 1999 Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure Circulation 99 3224 3226
27. B Bozkurt SB Kribbs FJ Clubb Jr 1998 Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats Circulation 97 1382 1391
28. N Sivasubramanian ML Coker KM Kurrelmeyer 2001 Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor Circulation 104 826 831